The institute is supported by a collaboration between Phoenix Children’s, The University of Arizona College of Medicine-Phoenix and the Translational Genomics Research Institute.
The institute’s goal is to use molecular medicine to develop individualized drugs for patients based on their genetic makeup. The team at the institute will focus on pediatric cancers first, and later expand to other pediatric diseases.
More Articles on Hospitals for Children:
6 Considerations Unique to Children’s Hospitals in the Drive to Greater Healthcare Value
Moody’s: 100 Statistics on Children’s Hospital Medians
Children’s Hospitals and Clinics of Minnesota Opens New ED
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
